Maravai Lifesciences Holdings (MRVI) Assets Average (2021 - 2026)

Maravai Lifesciences Holdings' Assets Average history runs 6 years deep, the most recent figure standing at $741.9 million for Q1 2026.

• In Q1 2026, Assets Average fell 24.6% year-over-year to $741.9 million; the TTM figure through Mar 2026 stood at $741.9 million (down 24.6% YoY), while the FY2025 annual figure was $889.4 million, down 28.72% from the prior year.
• Assets Average was $741.9 million for Q1 2026 at Maravai Lifesciences Holdings, down from $809.9 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $2.3 billion in Q1 2023 to a low of $741.9 million in Q1 2026.
• Historically, Assets Average has averaged $1.6 billion across 5 years, with a median of $1.5 billion in 2024.
• The sharpest annual moves came in 2022 and 2024: Assets Average jumped 51.06% in 2022, then slumped 39.94% in 2024.
• A 5-year view of Assets Average shows it stood at $2.3 billion in 2022, then fell by 17.13% to $1.9 billion in 2023, then sank by 39.11% to $1.1 billion in 2024, then retreated by 29.16% to $809.9 million in 2025, then dropped by 8.39% to $741.9 million in 2026.
• The last three Assets Average figures came in at $741.9 million (Q1 2026), $809.9 million (Q4 2025), and $873.1 million (Q3 2025), per Business Quant data.